Tamano S, Hasegawa R, Hagiwara A, Nagao M, Sugimura T, Ito N
First Department of Pathology, Nagoya City University Medical School, Japan.
Carcinogenesis. 1994 Sep;15(9):2009-15. doi: 10.1093/carcin/15.9.2009.
Carcinogenicity of 2-amino-3-methyl-9H-pyrido[2,3-b]-indole (MeA alpha C) was investigated at dietary levels of 0 (control), 0.01, 0.02, 0.04 and 0.08% using male F344/DuCrj rats. The administration of MeA alpha C was continued for 100 experimental weeks for the control, 0.01 and 0.02% groups, but halted after 52 and 26 experimental weeks for the 0.04 and 0.08% groups respectively due to severe toxicity. Well-differentiated hepatocellular carcinomas, lacking in control animals, were induced in 5/20 rats (25%) and 6/20 rats (30%) of the 0.01% and 0.02% groups respectively. Pancreatic acinar cell adenomas were also significantly increased in the 0.01% (30%) and 0.02% (40%) groups, in association with high incidences of hyperplastic lesions of acinar cells. Fibromas in the subcutis developed at a high incidence (70%) in the 0.02% group. MeA alpha C was also suggested to elicit fibrosarcomas in the salivary gland and transitional cell carcinomas in the urinary bladder. Among the non-neoplastic lesions, severe atrophy of the salivary glands and pancreas and severe renal toxicity were noteworthy. In conclusion, MeA alpha C is a multi-targeting carcinogen in rats, similar in this respect to other heterocyclic amines.
使用雄性F344/DuCrj大鼠,研究了2-氨基-3-甲基-9H-吡啶并[2,3-b]吲哚(MeAαC)在0(对照)、0.01%、0.02%、0.04%和0.08%饮食水平下的致癌性。对于对照组、0.01%和0.02%组,MeAαC的给药持续100个实验周,但对于0.04%和0.08%组,分别在52周和26周实验周后因严重毒性而停止给药。在0.01%组的20只大鼠中有5只(25%)和0.02%组的20只大鼠中有6只(30%)诱导出了对照组动物所没有的高分化肝细胞癌。胰腺腺泡细胞腺瘤在0.01%(30%)和0.02%(40%)组中也显著增加,同时伴有腺泡细胞增生性病变的高发生率。0.02%组皮下纤维瘤的发生率很高(70%)。还提示MeAαC可诱发唾液腺纤维肉瘤和膀胱移行细胞癌。在非肿瘤性病变中,值得注意的是唾液腺和胰腺的严重萎缩以及严重的肾毒性。总之,MeAαC是大鼠中的一种多靶点致癌物,在这方面与其他杂环胺类似。